Author:
Wong Y. Nancy,Burcham Deborah L.,Saxton Philip L.,Erickson-Viitanen Susan,Grubb Mary F.,Quon Check Y.,Huang Shiew-Mei
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine
Reference11 articles.
1. Active human immunodeficiency virus protease is required for viral infectivity.
2. The HIV-1 Protease as a Therapeutic Target for AIDS
3. Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol
4. , , , and , Disposition and bioavailability of HIV-protease inhibitor Ro 31–8959, after single doses in healthy volunteers. Proc. Br. Pharm. Soc., 8–10 April, 1992, 156P.
5. , , , and , Tolerability and pharmacokinetics of a single oral dose of Ro 31-8959, and HIV-protease inhibitor. Proc. Br. Pharm. Soc., 167P.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献